Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related GTP-binding protein C (RagC) is a small GTPase that plays a pivotal role in the nutrient-sensing pathway that activates the mechanistic target of rapamycin complex 1 (mTORC1). It functions as part of a heterodimer with RagA or RagB to recruit mTORC1 to the lysosomal surface, where it can be activated by Rheb. Recent research has identified that specific lysine residues on RagC (K15, K23, and K211) undergo β-hydroxybutyrylation (Kbhb), a post-translational modification induced by elevated levels of the ketone body β-hydroxybutyrate (BHB) during fasting or ketogenic states (He et al., 2024, Molecular Cell). This modification is catalyzed by the acetyltransferase p300 and serves to enhance the interaction between RagC and the mTORC1 component Raptor, thereby driving mTORC1 signaling independently of amino acid levels. In pathological contexts, such as hepatocellular carcinoma, this mechanism allows tumor cells to maintain growth signals even in nutrient-poor environments, identifying RagC β-hydroxybutyrylation as a potential therapeutic target. While direct inhibitors of RagC Kbhb are not yet clinically available, the pathway can be modulated via p300 inhibitors or HDAC inhibitors, which act as the "writer" and "eraser" of this modification, respectively. Targeting this specific metabolic-epigenetic axis offers a novel approach to treating cancers and metabolic diseases characterized by dysregulated mTORC1 activity.
Inhibition of p300-mediated β-hydroxybutyrylation of RagC to prevent mTORC1 lysosomal recruitment and subsequent activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related GTP-binding protein C (RagC) (RagC).